Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom

Humanigen, Inc. announced it has entered into an agreement with PCI Pharma Services to provide importation, release, and commercialization services in the United Kingdom for lenzilumab.